Prolonged Hospital Stay After Thoracoscopic Anatomical Lung Resections

NCT ID: NCT06638645

Last Updated: 2025-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

140 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-11-12

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the reasons for prolonged hospital stay after thoracoscopic (video- or robot-assisted) anatomical lung resections are investigated. Currently, whenever possible, these anatomical lung resections are performed thoracoscopically, as they offer significant improvements in terms of postoperative pain, number of postoperative complications, rehabilitation, tolerance for adjuvant chemotherapy, and length of hospital stay. The development of an 'Enhanced Recovery After Surgery' (ERAS) protocol for lung surgery has further reduced hospital stay and the need for opioids for analgesia. Despite the optimal implementation of the ERAS protocol, there are still patients who need to stay in the hospital longer than the median. The aim of this research is to investigate the reasons for this.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Minimally Invasive Surgical Procedures VATS RATS Surgery Pulmonary Lobectomy Pulmonary Segmentectomy Air Leakage Postoperative Complication Pain Postoperative

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients undergoing a minimally invasive anatomical lung resection

Patients undergoing a minimally invasive anatomical lung resection, receiving perioperative care according to the ERAS protocol for Lung Surgery

VATS/RATS anatomical lung resection

Intervention Type PROCEDURE

Perioperative care according to the ERAS protocol for lung surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

VATS/RATS anatomical lung resection

Perioperative care according to the ERAS protocol for lung surgery

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

VATS lobectomy RATS lobectomy VATS segmentectomy RATS segmentectomy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred for elective minimally invasive (uniportal or multiportal video- or robot-assisted) anatomical lung resection (lobectomy or segmentectomy)
* Informed consent obtained pre-operatively
* Age 18 years or older

Exclusion Criteria

* Patients younger than 18 years old
* Traumatic event as indication for lung resection
* Non-anatomical lung resections
* Thoracotomy
* Patients already hospitalized for other pathologies, pre-existent and not related to the lung surgery
* Urgent/emergency procedures
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AZ Sint-Lucas Brugge

OTHER

Sponsor Role collaborator

University Hospital, Ghent

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DienstThoracaleEnVasculaireHeelkunde

Clinical professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AZ Sint-Jan Brugge-Oostende AV

Bruges, , Belgium

Site Status RECRUITING

Ghent University Hospital

Ghent, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Liesbeth Desender, MD, PhD

Role: CONTACT

3293326148

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jan Lesaffer, MD

Role: primary

3250452560

Jan Lesaffer, MD

Role: backup

Liesbeth Desender, MD, PhD

Role: primary

3293326148

Lauren Villeirs, MD

Role: backup

Lauren Villeirs, MD

Role: backup

Liesbeth Desender, MD, PhD

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

THE-2024-0246

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.